# RTM Clinical Translation Blueprint: 
## Longitudinal iEEG Protocol for Seizure Prediction via Topological Collapse

**Document Type:** Clinical Trial Data Architecture & Protocol  
**Framework:** Multiscale Temporal Relativity (RTM) - Scale-Clock Geometry  
**Target Pathology:** Refractory Epilepsy (Pre-surgical Monitoring)  

---

## 1. Executive Summary & Clinical Rationale

Recent empirical validation of the RTM framework on the UCI Epileptic Dataset ($N=11,500$) established that an epileptic seizure represents a physical fracturing of the brain's multiscale topology. Rather than merely observing voltage spikes, RTM detects seizures as a violent collapse in the geometric coherence of the power-law fit (a drop in $R^2$, Cohen's $d = -1.55$). 

However, cross-sectional (population-level) data cannot yield a diagnostic device due to high inter-subject variance. To transition RTM into a functional Class III medical algorithm (e.g., for closed-loop neurostimulation devices like RNS), we must move from population averages to **intra-subject longitudinal calibration**.

**Study Objective:** To determine if the RTM topological collapse ($R^2$ degradation and $\alpha$ exponent drift) occurs in the *pre-ictal* phase (minutes before the clinical seizure), serving as a reliable Early Warning Signal (EWS) for individual patients.

---

## 2. The Ideal Dataset: What to Request from the Hospital

To avoid the "Modality Trap" (skull impedance destroying geometric coherence), this study strictly requires **Intracranial EEG (iEEG / ECoG / sEEG)** data. Scalp EEG is explicitly excluded for this phase.

### 2.1 Patient Cohort
* **N = 10 to 20 patients** undergoing continuous pre-surgical invasive monitoring for drug-resistant epilepsy.
* **Duration:** Minimum of 7 continuous days of recording per patient.

### 2.2 Data Specifications
* **Modality:** iEEG (depth electrodes or subdural grids).
* **Sampling Rate:** $\ge 500$ Hz (high temporal resolution is critical to capture the high-frequency fractal micro-structure).
* **Format:** European Data Format (.edf) or BIDS (Brain Imaging Data Structure).

### 2.3 Clinical Metadata (The "Ground Truth" Labels)
The hospital must provide a precise, neurologist-verified event log containing:
1. **Seizure Onset Time (Sub-second precision):** The exact electrical onset.
2. **Clinical Onset Time:** When the physical symptoms began.
3. **Seizure Offset Time:** When the electrical storm ended.
4. **Electrode Localization Map:** 3D coordinates of which channels are in the "Seizure Onset Zone" (SOZ) vs. "Healthy Tissue."
5. **Sleep/Wake Logs:** (Optional but highly recommended) To control for natural $\alpha$ shifts during the sleep cycle.

---

## 3. RTM Analytical Pipeline: The "Intra-Subject" Architecture

The computational pipeline will abandon static thresholds and implement a dynamic, personalized RTM baseline for each patient.

### Phase A: Personalized Baseline Calibration
For the first 24 hours of inter-ictal (seizure-free) recording, the algorithm will compute the RTM exponent ($\alpha$) and the coherence metric ($R^2$) using continuous Orthogonal Distance Regression (ODR) over 5-second sliding windows.
* **Output:** A calibrated "Healthy Fractal Signature" specifically parameterized for *Patient X* (e.g., Patient X normal $R^2 = 0.88 \pm 0.04$).

### Phase B: Spatial Contextualization (The Gradient)
Instead of averaging all electrodes, the RTM algorithm will calculate the topological gradient between the Seizure Onset Zone (SOZ) electrodes and the distant healthy electrodes. 
* **Hypothesis:** The SOZ will exhibit chronic, low-level topological degradation ($\alpha$ suppression) even during inter-ictal periods, acting as a spatial biomarker for surgical resection.

### Phase C: Pre-Ictal EWS Detection (The Collapse Test)
The core clinical test. We will analyze the 60 minutes preceding every recorded seizure.
* **Hypothesis:** Before the voltage spikes of the actual seizure, the brain enters a state of "Holonomy" (Regime Mixing). Different scales begin to decouple. 
* **Metric:** We are looking for a statistically significant drop in $R^2$ (falling below the patient's personalized baseline) *before* the neurologist's marked onset time.

---

## 4. Statistical Success Criteria

To prove clinical viability, the RTM algorithm must be evaluated on standard time-series forecasting metrics, not just $p$-values.

1. **Prediction Horizon (Time-to-Warning):** How many seconds/minutes before the clinical onset does the $R^2$ collapse trigger an alarm? (Target: $> 15$ seconds).
2. **Sensitivity (True Positive Rate):** Percentage of seizures successfully predicted by the RTM threshold.
3. **Time-in-False-Alarm (TiFA):** The fraction of the day the algorithm falsely claims a seizure is imminent. (Target: $< 5\%$).

---

## 5. Phased Execution Plan

* **Phase 1 (Retrospective):** Request historical, anonymized iEEG data from completed surgical cases. Run the RTM algorithm blindly, then compare the algorithm's "alarms" against the neurologist's event logs.
* **Phase 2 (Prospective/Simulated Live):** Stream historical data into the RTM pipeline sequentially, simulating a live ICU monitor to test computational efficiency and EWS timing.
* **Phase 3 (Hardware Integration):** Partner with neuro-device manufacturers to embed the RTM ODR calculation directly onto the firmware of closed-loop neurostimulators, replacing raw-voltage triggers with topological triggers.